Title:
CATARACT INHIBITOR
Document Type and Number:
Japanese Patent JP2019156804
Kind Code:
A
Abstract:
To provide novel effective agents for cataract treatment.SOLUTION: Provided is a cataract inhibitor or therapeutic agent that contains a culture supernatant component obtained by culturing mesenchymal stem cells. Preferably, provided is an inhibitor or therapeutic agent that comprises the culture supernatant component of bone marrow mesenchymal stem cells or adipose tissue-derived mesenchymal stem cells. Preferably, provided is an inhibitor or therapeutic agent that comprises an exosome. Preferably, provided is an inhibitor or therapeutic agent that is an eye drop or an ophthalmic ointment.SELECTED DRAWING: None
More Like This:
| JP6483187 | Enhanced stem cell composition |
| WO/2023/064383 | SYSTEMS AND METHODS FOR MANUFACTURING OF THERAPEUTIC CELLS |
| WO/2018/182016 | CELL CULTURING USING NANOFIBERS |
Inventors:
YAMAGUCHI TATSUYA
Application Number:
JP2018049174A
Publication Date:
September 19, 2019
Filing Date:
March 16, 2018
Export Citation:
Assignee:
TOYO BOSEKI
International Classes:
A61K35/28; A61K9/06; A61K9/08; A61P27/12
Domestic Patent References:
| JP2017158488A | 2017-09-14 | |||
| JP2017176043A | 2017-10-05 | |||
| JP2018033419A | 2018-03-08 | |||
| JP2017143775A | 2017-08-24 |
Foreign References:
| US20110225661A1 | 2011-09-15 |